share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股SEC公告 ·  08/20 16:28
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 08/20/2024, as per the latest filing. These shares, valued at approximately $81,532.92, were originally acquired as founder's shares on 09/01/2016 as compensation from the issuer. This planned sale follows a series of transactions over the past three months, where Borgeson sold a total of 68,682 Class A shares, generating gross proceeds of $569,369.77. The upcoming sale continues Borgeson's pattern of share disposals, which have been regularly occurring since May 2024.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 08/20/2024, as per the latest filing. These shares, valued at approximately $81,532.92, were originally acquired as founder's shares on 09/01/2016 as compensation from the issuer. This planned sale follows a series of transactions over the past three months, where Borgeson sold a total of 68,682 Class A shares, generating gross proceeds of $569,369.77. The upcoming sale continues Borgeson's pattern of share disposals, which have been regularly occurring since May 2024.
Recursion Pharmaceuticals,Inc.董事Blake Borgeson计划在2024年08月20日出售公司的11,447股A类股份,根据最新的文件披露。这些股份价值大约81532.92美元,最初于2016年09月01日作为发行人的补偿获得。此次计划出售是Borgeson在过去三个月里进行的一系列交易之后进行的,他共出售了68,682股A类股票,获得了569,369.77美元的收益。即将到来的销售延续了Borgeson持续自2024年5月以来的股票处置模式。
Recursion Pharmaceuticals,Inc.董事Blake Borgeson计划在2024年08月20日出售公司的11,447股A类股份,根据最新的文件披露。这些股份价值大约81532.92美元,最初于2016年09月01日作为发行人的补偿获得。此次计划出售是Borgeson在过去三个月里进行的一系列交易之后进行的,他共出售了68,682股A类股票,获得了569,369.77美元的收益。即将到来的销售延续了Borgeson持续自2024年5月以来的股票处置模式。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息